Patent ID: 8435966
Filing Date: 2013-05-07
Classification: A61K,A61P,C07C,C08B

Abstract:
1. Pharmaceutical formulation containing association products containing a xanthate of formula I whereby R 1 represents an adamantyl, norbornyl, tricyclodecyl, benzyl, linear or branched C 1 -C 20 alkyl, C 3 -C 20 cycloalkyl, furyl, pyridyl, anthracyl, naphthyl, phenanthryl, perinaphthyl or quinuclidinyl residue, and the above-mentioned linear or branched C 1 -C 20 alkyl residue can be substituted with a hydroxyl, a C 1 -C 4 alkoxy group, a halogen atom or an amino group, and the above-mentioned C 3 -C 20 cycloalkyl residue can be substituted with a hydroxyl, a C 1 -C 4 alkoxy or C 1 -C 4 alkyl group, a halogen atom or an amino group and R 2 represents a metal atom other than a metal atom selected from the group consisting of platinum, gold, copper, nickel, rhodium, ruthenium, bismuth, and palladium, an unsubstituted or substituted alkyl, alkoxy, amino or ammonium group, a cleavable group comprising a substituent containing an ester group, or halogen, and a cyclodextrin.